Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Preferred Dividend Payments (2023 - 2025)

TriSalus Life Sciences (TLSI) has 3 years of Preferred Dividend Payments data on record, last reported at -$1.4 million in Q4 2025.

  • For Q4 2025, Preferred Dividend Payments rose 40.71% year-over-year to -$1.4 million; the TTM value through Dec 2025 reached $11.9 million, changed N/A, while the annual FY2025 figure was $11.9 million, N/A changed from the prior year.
  • Preferred Dividend Payments reached -$1.4 million in Q4 2025 per TLSI's latest filing, down from $11.9 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $11.9 million in Q3 2025 and bottomed at -$2.4 million in Q4 2024.
  • Average Preferred Dividend Payments over 3 years is $1.3 million, with a median of $757000.0 recorded in 2023.
  • Peak YoY movement for Preferred Dividend Payments: tumbled 400.62% in 2024, then surged 1387.8% in 2025.
  • A 3-year view of Preferred Dividend Payments shows it stood at $800000.0 in 2023, then crashed by 400.62% to -$2.4 million in 2024, then soared by 40.71% to -$1.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Preferred Dividend Payments were -$1.4 million in Q4 2025, $11.9 million in Q3 2025, and $714000.0 in Q2 2025.